BN-82451 dihydrochloride is an orally active, centrally penetrant antioxidant and multitarget neuroprotective agent that has demonstrated significant protective effects in experimental animal models of cerebral ischemia, Parkinson's disease, Huntington's disease, and particularly amyotrophic lateral sclerosis (ALS).